scispace - formally typeset
C

Carlos A. M. Afonso

Researcher at University of Lisbon

Publications -  434
Citations -  15782

Carlos A. M. Afonso is an academic researcher from University of Lisbon. The author has contributed to research in topics: Ionic liquid & Catalysis. The author has an hindex of 57, co-authored 413 publications receiving 13891 citations. Previous affiliations of Carlos A. M. Afonso include University of Porto & Universidade Nova de Lisboa.

Papers
More filters
Journal ArticleDOI

Comparison of physicochemical properties of new ionic liquids based on imidazolium, quaternary ammonium, and guanidinium cations

TL;DR: The features of the solid-liquid phase transition were analyzed, namely the glass transition temperature and the heat capacity jump associated with the transition from the non-equilibrium glass to the metastable supercooled liquid.
Journal ArticleDOI

Highly Selective Transport of Organic Compounds by Using Supported Liquid Membranes Based on Ionic Liquids

TL;DR: The potential for continuous separation of organic compounds based on the selective transport through supported liquid membranes that contain RTILs is shown, mainly because of the nonvolatile character ofRTILs and their solubility in the surrounding phases.
Journal ArticleDOI

Pyridinium salts: from synthesis to reactivity and applications

TL;DR: This review aims at highlighting the pyridinium salts in terms of their synthetic routes, reactivity and their importance as pyrIDinium ionic liquids, as p Pyrid inium ylides, as anti-microbial, anti-cancer,Anti-malarial and anti-cholinesterase inhibitors, as well as their applications in materials science and biological issues related to gene delivery.
Journal ArticleDOI

Synthesis of Chiral Cyclopentenones.

TL;DR: This Review provides an overview of reported methods for enantioselective and asymmetric syntheses of cyclopentenones, including chemical and enzymatic resolution, asymmetric synthesis via Pauson-Khand reaction, Nazarov cyclization and organocatalyzed reactions, asymmetrical functionalization of the existing cyclopENTenone unit, andfunctionalization of chiral building blocks.